Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

22nd Century Group Inc (XXII)

22nd Century Group Inc (XXII)
0.8100 x 2 0.8258 x 2
Post-market by (Cboe BZX)
0.8260 +0.0690 (+9.11%) 04/23/25 [NASDAQ]
0.8100 x 2 0.8258 x 2
Post-market 0.8258 -0.0002 (-0.02%) 17:11 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.7500
Day High
0.8279
Open 0.7570
Previous Close 0.7570 0.7570
Volume 212,875 212,875
Avg Vol 1,618,304 1,618,304
Stochastic %K 4.60% 4.60%
Weighted Alpha -98.70 -98.70
5-Day Change -0.0030 (-0.36%) -0.0030 (-0.36%)
52-Week Range 0.7000 - 265.9500 0.7000 - 265.9500
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,794
  • Shares Outstanding, K 2,370
  • Annual Sales, $ 24,380 K
  • Annual Income, $ -15,160 K
  • EBIT $ -14 M
  • EBITDA $ -13 M
  • 60-Month Beta 2.03
  • Price/Sales 0.07
  • Price/Cash Flow N/A
  • Price/Book 0.32
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -354.05
  • Most Recent Earnings $-72.97 on 11/12/24
  • Next Earnings Date 05/21/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Consumer Staples
  • INDUSTRY GROUPING Tobacco

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 96.80%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.87
  • Number of Estimates 1
  • High Estimate -0.87
  • Low Estimate -0.87
  • Prior Year -232.43
  • Growth Rate Est. (year over year) +99.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7000 +18.00%
on 04/16/25
Period Open: 1.7100
2.4400 -66.15%
on 04/09/25
-0.8840 (-51.70%)
since 03/21/25
3-Month
0.7000 +18.00%
on 04/16/25
Period Open: 5.1200
5.3600 -84.59%
on 01/24/25
-4.2940 (-83.87%)
since 01/23/25
52-Week
0.7000 +18.00%
on 04/16/25
Period Open: 225.4500
265.9500 -99.69%
on 04/26/24
-224.6240 (-99.63%)
since 04/23/24

Most Recent Stories

More News
22nd Century Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

XXII : 0.8260 (+9.11%)
Emerging Growth Research Releases Quarterly Update Report on 22nd Century Group (XXII)

Sheridan, Wyoming--(Newsfile Corp. - April 10, 2025) - Emerging Growth Research is pleased to release its latest quarterly update on 22nd Century Group, Inc. (NASDAQ: XXII), following the Company's Q4...

XXII : 0.8260 (+9.11%)
22nd Century Revenue Growth from Continued Expansion of CMO Volume with New Filtered Cigar Agreements

XXII : 0.8260 (+9.11%)
22nd Century CEO & Chairman Larry Firestone Provides Corporate Update Letter to Stockholders

XXII : 0.8260 (+9.11%)
22nd Century Group Reports Fourth Quarter and Full Year 2024 Financial Results 

XXII : 0.8260 (+9.11%)
22nd Century Group to Announce Fourth Quarter and Full Year 2024 Results on March 20, 2025

XXII : 0.8260 (+9.11%)
22nd Century Announces First Partner VLN Agreement, New VLN Availability with Smoker Friendly

XXII : 0.8260 (+9.11%)
Emerging Growth Research Releases New Initiation Report on the 22nd Century Group (XXII)

Sheridan, Wyoming--(Newsfile Corp. - February 19, 2025) - Emerging Growth Research is pleased to announce the release of its new initiation report on the 22nd Century Group, Inc. (NASDAQ: XXII). The Company...

XXII : 0.8260 (+9.11%)
22nd Century to Present at the Emerging Growth Conference on February 19, 2025

XXII : 0.8260 (+9.11%)
22nd Century Regains Full Compliance with Nasdaq Continued Listing Standards

XXII : 0.8260 (+9.11%)

Business Summary

22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products...

See More

Key Turning Points

3rd Resistance Point 0.8560
2nd Resistance Point 0.8140
1st Resistance Point 0.7855
Last Price 0.8260
1st Support Level 0.7150
2nd Support Level 0.6730
3rd Support Level 0.6445

See More

52-Week High 265.9500
Fibonacci 61.8% 164.6245
Fibonacci 50% 133.3250
Fibonacci 38.2% 102.0255
Last Price 0.8260
52-Week Low 0.7000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective